Search research articles
Contact Us
Filters
Showing results (31-40 of 90) with videos related to
Page
of 9
Sort By:
Clinical and Experimental Pharmacology & Physiology
|
September 14, 2017
C1q/TNF-related protein 9 improves the anti-contractile effects of perivascular adipose tissue via the AMPK-eNOS pathway in diet-induced obese mice
Fang Han, Yang Zhang, Mingxia Shao, et al.
BMJ Open
|
March 17, 2023
Secular trends of epidemiologic patterns of chronic kidney disease over three decades: an updated analysis of the Global Burden of Disease Study 2019
Xiaojin Feng, Ningning Hou, Zhenna Chen, et al.
Phytotherapy Research : PTR
|
July 8, 2025
Therapeutic Potential of Ginsenosides in the Treatment of Endocrine Diseases: Roles and Mechanisms
Jing Li, Hongyan Qiu, Xiaoxiao Liu, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association
|
February 8, 2026
Micro- and Nanoplastics and PM2.5 in Cardiovascular Disease: Emerging Mechanisms, Impacts, and Therapeutic Insights
Silin Kong, Kexin Zhang, Jiajun Sang, et al.
European Journal of Gastroenterology & Hepatology
|
December 4, 2025
Epidemiology of metabolic dysfunction-associated steatotic liver disease -related liver diseases: 1990-2021 and projections to 2045
Chengxia Kan, Kexin Zhang, Ningning Hou, et al.
Journal of Anxiety Disorders
|
March 21, 2026
Trends and determinants of childhood anxiety disorders burden in Asia, 1990-2023
Kexin Zhang, Chengxia Kan, Fang Han, et al.
Life Sciences
|
June 11, 2024
Emerging therapeutic landscape: Incretin agonists in chronic kidney disease management
Kexin Lian, Kexin Zhang, Chengxia Kan, et al.
Frontiers in Pharmacology
|
January 7, 2022
Transcriptomic Analysis Reveals the Protective Effects of Empagliflozin on Lipid Metabolism in Nonalcoholic Fatty Liver Disease
Yuting Ma, Chengxia Kan, Hongyan Qiu, et al.
Clinical and Experimental Pharmacology & Physiology
|
August 7, 2020
Liraglutide improves obesity-induced renal injury by alleviating uncoupling of the glomerular VEGF-NO axis in obese mice
Kai Li, Jinhong Sun, Na Huang, et al.
American Journal of Physiology. Endocrinology and Metabolism
|
October 6, 2025
Ribosome collisions and ZAKα activation: explores the therapeutic potential of metabolic diseases
Wenqiang Zhang, Kexin Zhang, Chengxia Kan, et al.
Page
of 9
Search research articles
Search
Showing results (31-40 of 90) with videos related to
Sort By:
Page
of 9
Clinical and Experimental Pharmacology & Physiology
|
September 14, 2017
C1q/TNF-related protein 9 improves the anti-contractile effects of perivascular adipose tissue via the AMPK-eNOS pathway in diet-induced obese mice
Fang Han, Yang Zhang, Mingxia Shao, et al.
BMJ Open
|
March 17, 2023
Secular trends of epidemiologic patterns of chronic kidney disease over three decades: an updated analysis of the Global Burden of Disease Study 2019
Xiaojin Feng, Ningning Hou, Zhenna Chen, et al.
Phytotherapy Research : PTR
|
July 8, 2025
Therapeutic Potential of Ginsenosides in the Treatment of Endocrine Diseases: Roles and Mechanisms
Jing Li, Hongyan Qiu, Xiaoxiao Liu, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association
|
February 8, 2026
Micro- and Nanoplastics and PM2.5 in Cardiovascular Disease: Emerging Mechanisms, Impacts, and Therapeutic Insights
Silin Kong, Kexin Zhang, Jiajun Sang, et al.
European Journal of Gastroenterology & Hepatology
|
December 4, 2025
Epidemiology of metabolic dysfunction-associated steatotic liver disease -related liver diseases: 1990-2021 and projections to 2045
Chengxia Kan, Kexin Zhang, Ningning Hou, et al.
Journal of Anxiety Disorders
|
March 21, 2026
Trends and determinants of childhood anxiety disorders burden in Asia, 1990-2023
Kexin Zhang, Chengxia Kan, Fang Han, et al.
Life Sciences
|
June 11, 2024
Emerging therapeutic landscape: Incretin agonists in chronic kidney disease management
Kexin Lian, Kexin Zhang, Chengxia Kan, et al.
Frontiers in Pharmacology
|
January 7, 2022
Transcriptomic Analysis Reveals the Protective Effects of Empagliflozin on Lipid Metabolism in Nonalcoholic Fatty Liver Disease
Yuting Ma, Chengxia Kan, Hongyan Qiu, et al.
Clinical and Experimental Pharmacology & Physiology
|
August 7, 2020
Liraglutide improves obesity-induced renal injury by alleviating uncoupling of the glomerular VEGF-NO axis in obese mice
Kai Li, Jinhong Sun, Na Huang, et al.
American Journal of Physiology. Endocrinology and Metabolism
|
October 6, 2025
Ribosome collisions and ZAKα activation: explores the therapeutic potential of metabolic diseases
Wenqiang Zhang, Kexin Zhang, Chengxia Kan, et al.
Page
of 9